80739-0812 KRAZATI - CanMED: NDC

Product NDC:

80739-0812

Brand Name:

KRAZATI

Generic Name:

Adagrasib

Dosage Form Name:

TABLET, COATED

Administration Route:

Oral

Substances:

Name: ADAGRASIB

Strength: 200.0

Unit: mg/1

Packages:

Code: 80739-0812-12

Description: 1 BOTTLE in 1 CARTON (80739-812-12) / 120 TABLET, COATED in 1 BOTTLE

Effective Date: Dec. 12, 2022

Discontinued:

Code: 80739-0812-18

Description: 1 BOTTLE in 1 CARTON (80739-812-18) / 180 TABLET, COATED in 1 BOTTLE

Effective Date: Dec. 12, 2022

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

RAS Inhibitor

Minor Class:

KRAS G12C

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox